DK125693D0 - - Google Patents

Info

Publication number
DK125693D0
DK125693D0 DK931256A DK125693A DK125693D0 DK 125693 D0 DK125693 D0 DK 125693D0 DK 931256 A DK931256 A DK 931256A DK 125693 A DK125693 A DK 125693A DK 125693 D0 DK125693 D0 DK 125693D0
Authority
DK
Denmark
Application number
DK931256A
Other languages
Danish (da)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK931256A priority Critical patent/DK125693D0/da
Publication of DK125693D0 publication Critical patent/DK125693D0/da
Priority to IL11150194A priority patent/IL111501A0/en
Priority to AU80581/94A priority patent/AU8058194A/en
Priority to PCT/DK1994/000414 priority patent/WO1995012407A1/en
Priority to ZA948721A priority patent/ZA948721B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
DK931256A 1993-11-05 1993-11-05 DK125693D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DK931256A DK125693D0 (en) 1993-11-05 1993-11-05
IL11150194A IL111501A0 (en) 1993-11-05 1994-11-02 Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis
AU80581/94A AU8058194A (en) 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis
PCT/DK1994/000414 WO1995012407A1 (en) 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis
ZA948721A ZA948721B (en) 1993-11-05 1994-11-04 A method of treating coronary thrombosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK931256A DK125693D0 (en) 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
DK125693D0 true DK125693D0 (en) 1993-11-05

Family

ID=8102801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK931256A DK125693D0 (en) 1993-11-05 1993-11-05

Country Status (5)

Country Link
AU (1) AU8058194A (en)
DK (1) DK125693D0 (en)
IL (1) IL111501A0 (en)
WO (1) WO1995012407A1 (en)
ZA (1) ZA948721B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
CN106890320A (en) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 It is a kind of for preventing or treating acute and Chronic Thrombotic method
ES2961967T3 (en) 2015-12-18 2024-03-14 Talengen Int Ltd Plasminogen for use in the treatment of diabetic angiocardiopathy
TWI653982B (en) 2015-12-18 2019-03-21 大陸商深圳瑞健生命科學研究院有限公司 Method for preventing or treating acute and chronic thrombosis
EP3556390B1 (en) 2016-12-15 2024-04-03 Talengen International Limited Plasminogen for use in treating diabetes
CA3047175A1 (en) 2016-12-15 2018-06-21 Talengen International Limited Method for mitigating heart disease
TWI746580B (en) 2016-12-15 2021-11-21 大陸商深圳瑞健生命科學硏究院有限公司 Use of plasminogen in preparing medicine for preventing and treating fat metabolism disorder and related diseases
CA3047181A1 (en) 2016-12-15 2018-06-21 Talengen International Limited Method and drug for preventing and treating obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1991015235A1 (en) * 1990-03-30 1991-10-17 Survival Technology, Inc. t-PA ENHANCER PROFILE

Also Published As

Publication number Publication date
WO1995012407A1 (en) 1995-05-11
AU8058194A (en) 1995-05-23
ZA948721B (en) 1995-05-08
IL111501A0 (en) 1995-01-24

Similar Documents

Publication Publication Date Title
DE9306785U1 (en)
DE9303231U1 (en)
DE9302586U1 (en)
DE9302891U1 (en)
DK125693D0 (en)
DE9302125U1 (en)
DE9306377U1 (en)
DE9305499U1 (en)
DE9301515U1 (en)
DE9301028U1 (en)
DE9300529U1 (en)
DE9306248U1 (en)
DE9301755U1 (en)
DE9301609U1 (en)
DE9300820U1 (en)
DE9301320U1 (en)
DE9302139U1 (en)
DE9300319U1 (en)
DE9300330U1 (en)
DE9301339U1 (en)
DE9302802U1 (en)
DE9307119U1 (en)
DE9301102U1 (en)
DE9302666U1 (en)
DE9305522U1 (en)

Legal Events

Date Code Title Description
A0 Application filed
ATS Application withdrawn